2021 journal article

Treatment of feline gastrointestinal intermediate- or large-cell lymphoma with lomustine chemotherapy and 8 Gy abdominal cavity radiation therapy

JOURNAL OF FELINE MEDICINE AND SURGERY, 23(6), 469–476.

By: T. Gieger n , G. Seiler n & M. Nolan n

author keywords: Gastrointestinal lymphoma; lymphoblastic lymphoma; large-cell lymphoma; chemotherapy; radiation therapy
MeSH headings : Abdominal Cavity; Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases / drug therapy; Cats; Gastrointestinal Tract; Lomustine / therapeutic use; Lymphoma / drug therapy; Lymphoma / veterinary; Prospective Studies; Treatment Outcome
TL;DR: Treatment was seemingly well tolerated in most cats and was relatively cost-effective, so it is plausible that improved disease control may be achievable through continued optimization and intensification of the combinatorial chemoradiotherapy protocol. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: October 26, 2020

Objectives The goal of this study was to document the outcomes and toxicity of a novel multimodality treatment protocol for feline gastrointestinal intermediate- or large-cell lymphoma (FGL) in which cats were treated at 21-day intervals.